STOCK TITAN
  1. Home
  2. BIOTU

Biotech Acquisition Co Stock Price, News & Analysis

BIOTU NASDAQ

Company Description

Biotech Acquisition Co (NASDAQ: BIOTU) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

BIOTU stock has gained 1.7% over the past year.

This page provides a comprehensive overview of BIOTU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+1.71%
Performance 1 year
$0.0
Market Cap
23.0M
Shares outstanding

Biotech Acquisition Co (BIOTU) stock. Over the past 12 months, the stock has gained 1.7%.

Latest News

View All
-7.65%

Biotech Acquisition Company Announces Liquidation

acquisition
0.00%

Blade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology Conference

conferences
-0.20%

Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference

clinical trial
-0.10%

Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference

clinical trial
-0.15%

Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package

clinical trial fda approval
0.00%

Blade Therapeutics to Present Data from Preclinical and Phase 1 Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference

conferences clinical trial

Biotech Acquisition Co has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, conferences, clinical trial, fda approval. View all BIOTU news →

SEC Filings

View All

No SEC filings available for BIOTU.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

BIOTU Company Profile & Sector Positioning

Biotech Acquisition Co (BIOTU) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.